11.84

4.04% 0.46

Pre-market: 11.97 0.13 +1.10%

Omeros Corporation (OMER)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Omeros Corporation stock is traded at $11.84, with a volume of 774.77K. It is up +4.04% in the last 24 hours and up +5.81% over the past month. Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Previous Close:

$11.38

Open:

$11.48

24h Volume:

774.77K

Relative Volume:

0.58

Market Cap:

$852.43M

Revenue:

Net Income/Loss:

$-4.81M

P/E Ratio:

-23.69

EPS:

-0.4998

Net Cash Flow:

$-122.54M

1W Performance:

+7.83%

1M Performance:

+5.81%

6M Performance:

+188.78%

1Y Performance:

+69.38%

1-Day Range:

$11.46

$11.84

1-Week Range:

$10.93

$12.02

52-Week Range:

$2.95

$17.65

Omeros Corporation Stock (OMER) Company Profile

Name

Omeros Corporation

Sector

Healthcare (1110)

Industry

Biotechnology (622)

Phone

206-676-5000

Address

201 ELLIOTT AVENUE WEST, SEATTLE, WA

Employee

175

Twitter

@OmerosCorp

Next Earnings Date

2026-03-31

Latest SEC Filings

OMER's Discussions on Twitter

Compare OMER vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OMER Omeros Corporation	11.84	827.24M	0	-4.81M	-122.54M	-0.4998
VRTX Vertex Pharmaceuticals Inc	444.28	110.97B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	755.51	79.17B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	828.35	49.73B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	339.41	42.98B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	310.00	34.37B	5.36B	287.73M	924.18M	2.5229

Omeros Corporation Stock (OMER) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-10-25	Initiated	H.C. Wainwright	Buy
Dec-23-24	Initiated	D. Boral Capital	Buy
Nov-14-24	Initiated	Rodman & Renshaw	Buy
Dec-08-22	Downgrade	UBS	Buy → Neutral
Nov-08-22	Downgrade	BofA Securities	Neutral → Underperform
Jun-08-22	Downgrade	BofA Securities	Buy → Neutral
Oct-08-21	Downgrade	JP Morgan	Neutral → Underweight
Oct-01-21	Downgrade	Maxim Group	Buy → Hold
Oct-01-21	Downgrade	Wedbush	Neutral → Underperform
Sep-27-21	Initiated	JP Morgan	Neutral
Feb-01-21	Initiated	UBS	Buy
Oct-20-20	Initiated	BofA Securities	Buy
Aug-21-20	Reiterated	H.C. Wainwright	Buy
Aug-14-20	Reiterated	Maxim Group	Buy
May-06-19	Initiated	Cantor Fitzgerald	Overweight
Jul-12-18	Initiated	Seaport Global Securities	Buy
Mar-23-18	Downgrade	Wedbush	Outperform → Neutral
Mar-05-18	Downgrade	Needham	Buy → Hold
Nov-08-17	Initiated	H.C. Wainwright	Buy
May-11-17	Downgrade	Cantor Fitzgerald	Buy → Neutral
Mar-17-17	Reiterated	Maxim Group	Buy
Mar-17-17	Reiterated	Needham	Buy
Nov-16-16	Reiterated	Wedbush	Outperform
Nov-10-16	Reiterated	Needham	Buy
Aug-10-16	Reiterated	Maxim Group	Buy
Jun-03-16	Initiated	Cantor Fitzgerald	Buy
Mar-02-16	Reiterated	Needham	Buy
Feb-29-16	Reiterated	Wedbush	Outperform
Nov-11-15	Reiterated	Needham	Buy
Aug-18-15	Reiterated	WBB Securities	Strong Buy
Aug-10-15	Initiated	ROTH Capital	Buy

View All

Omeros Corporation Stock (OMER) Latest News

Apr 13, 2026

Published on: 2026-04-14 03:02:37 - baoquankhu1.vn

Apr 13, 2026

OMER stock surges 5% after hours on Novo Nordisk deal windfall and drug launch optimism - MSN

Apr 13, 2026

Apr 12, 2026

Omeros rises as Novo deal boosts Q4 earnings - MSN

Apr 12, 2026

Omeros Corporation (NASDAQ:OMER) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 12, 2026

Apr 10, 2026

Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect? - Yahoo Finance

Apr 10, 2026

OMER News | OMEROS CORP (NASDAQ:OMER) - ChartMill

Apr 10, 2026

Earnings Risk: What is the long term forecast for Omeros Corporation stock2026 Technicals & Weekly Momentum Picks - baoquankhu1.vn

Apr 10, 2026

Apr 08, 2026

Omeros expects YARTEMLEA to be financially self-sustaining in 2026 and targets positive cash flow in 2027 - MSN

Apr 08, 2026